With your own knowledge and the help of the following document:

Document 1 (Title: Developmental Foundations of Cranial Neurological Structures): The embryological origins of cranial structures profoundly influence their pathological susceptibilities, with neoplastic transformations often recapitulating the developmental potential of their progenitor tissues. The neural tube, derived from neuroectodermal invagination during primary neurulation, gives rise to the central nervous system, including the brain, spinal cord, and ventricular system. Surface ectoderm contributes to sensory epithelia including the crystalline lens and inner ear sensory cells, while maintaining its capacity to develop keratin-producing squamous neoplasms. The notochord, a mesodermal structure defining the embryonic axis, induces neural plate formation and later contributes to the nucleus pulposus of intervertebral discs. Neural crest cells represent a unique embryological population arising from the dorsal neural tube that undergoes extensive migration and remarkable phenotypic diversification. These pluripotent cells contribute to numerous structures including cranial sensory ganglia, autonomic ganglia, Schwann cells, melanocytes, and elements of pharyngeal arch derivatives. The predilection for neural crest-derived tissues to develop neoplastic conditions reflects their inherent developmental plasticity and migratory capacity. Tumors specifically derived from Schwann cells, which form myelin sheaths around peripheral nerves, include schwannomas and neurofibromas. Bilateral vestibular schwannomas localized to the cerebellopontine angle represent the pathognomonic feature of neurofibromatosis type 2, an autosomal dominant condition caused by mutations in the NF2 tumor suppressor gene on chromosome 22. The association of cutaneous manifestations with neurological findings in these neurocutaneous syndromes directly reflects the common neural crest origin of both peripheral nerve sheath cells and melanocytes.
Document 2 (Title: Teratogenic Viral Infections During Pregnancy): Maternal infections during pregnancy represent significant causes of congenital anomalies, with rubella virus historically exemplifying teratogenic potential during critical periods of organogenesis. Rubella (German measles) transmitted to the developing fetus during early gestation results in a constellation of defects collectively termed congenital rubella syndrome (CRS). The pathophysiological mechanisms involve direct viral cytopathic effects and vascular disruption, with viral tropism for endothelial cells, epithelial cells, and certain fetal tissues including cardiac, ocular, cochlear, and central nervous system structures. The timing of maternal infection critically influences both transmission risk and pattern of defects, with first-trimester infection carrying the highest risk (up to 85% transmission) and greatest severity. The classic triad of congenital heart disease, cataracts, and sensorineural hearing loss characterizes severe manifestations, though affected infants may present with a spectrum of additional anomalies including microcephaly, intellectual disability, hepatosplenomegaly, thrombocytopenia, and characteristic blueberry muffin lesions reflecting extramedullary hematopoiesis. Cardiac defects predominantly involve the pulmonary artery and ductus arteriosus, with patent ductus arteriosus (PDA) representing the most common lesion, followed by peripheral pulmonary artery stenosis and septal defects. This predilection for right-sided cardiac structures and outflow tracts contrasts with the ventricular septal defects more commonly associated with certain other teratogenic exposures. Widespread rubella vaccination has dramatically reduced CRS incidence in developed nations, though maternal infection remains a significant concern in regions with inadequate immunization coverage. Notably, rubella shares features with other congenital infections comprising the TORCH complex (Toxoplasmosis, Other agents, Rubella, Cytomegalovirus, Herpes simplex), with distinctive patterns of end-organ involvement reflecting specific tropisms and pathogenic mechanisms. Definitive diagnosis relies on virus isolation, viral RNA detection, or specific IgM antibody detection in neonatal specimens, with congenital infection distinguished from acquired disease through persistence of IgG beyond the expected decay of maternal antibodies.
Document 3 (Title: Neurological Emergencies in Oncology): Spinal cord compression syndromes represent potentially devastating neurological emergencies requiring prompt recognition and intervention to prevent permanent neurological deficits. Among these, cauda equina syndrome (CES) deserves particular attention due to its distinct anatomical and clinical considerations. Unlike compression at higher spinal levels, CES involves compression of the lumbar and sacral nerve roots below the conus medullaris (L1-L2 level), which constitute the cauda equina. Metastatic disease, particularly from primary tumors with predilection for skeletal spread such as prostate, breast, and lung carcinomas, represents a common etiology in the oncological population. The clinical presentation of CES is characterized by a constellation of symptoms and signs including low back pain (present in >90% of cases), bilateral lower extremity weakness or sensory deficits (often asymmetric), saddle anesthesia (reduced sensation in perineal, perianal, and genital regions), and bowel or bladder dysfunction. Notably, saddle anesthesia represents a highly sensitive finding that may precede overt bladder or bowel dysfunction. Reflex abnormalities, particularly hyporeflexia of lower extremity deep tendon reflexes, reflect interruption of reflex arcs due to compression of cauda equina nerve roots. Management constitutes a true neurological emergency with initiation of high-dose intravenous corticosteroids (typically dexamethasone) representing the critical first intervention to reduce edema and inflammation surrounding the compressed neural elements. This should be administered immediately upon clinical suspicion, even before confirmatory imaging, as the time to treatment directly correlates with neurological outcomes. MRI represents the gold standard imaging modality, offering superior visualization of neural elements and the compressive pathology.

Answer the following multiple-choice question.
Question: A 23-year-old man comes to the physician for evaluation of decreased hearing, dizziness, and ringing in his right ear for the past 6 months. Physical examination shows multiple soft, yellow plaques and papules on his arms, chest, and back. There is sensorineural hearing loss and weakness of facial muscles bilaterally. His gait is unsteady. An MRI of the brain shows a 3-cm mass near the right internal auditory meatus and a 2-cm mass at the left cerebellopontine angle. The abnormal cells in these masses are most likely derived from which of the following embryological structures?
Options:
A. Neural tube
B. Surface ectoderm
C. Neural crest
D. Notochord

Respond strictly in valid JSON format as follows:
{"answer_choice": "A"} ‚Üê if A is the answer
Output only the JSON object. Do not include any explanation, commentary, markdown, or extra text.